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ABSTRACT Although phlorizin inhibition of Na-glucose cotransport occurs within a few seconds, 3H-phlorizin binding to
the sodium-coupled glucose transport protein(s) requires several minutes to reach equilibrium (the fast-acting slow-binding
paradigm). Using kinetic models of arbitrary dimension that can be reduced to a two-state diagram according to Cha’s
formalism, we show that three basic mechanisms of inhibitor binding can be identified whereby the inhibitor binding step
either (A) represents, (B) precedes, or (C) follows the rate-limiting step in a binding reaction. We demonstrate that each of
mechanisms A–C is associated with a set of unique kinetic properties, and that the time scale over which one may expect
to observe mechanism C is conditioned by the turnover number of the catalytic cycle. In contrast, mechanisms A and B may
be relevant to either fast-acting or slow-binding inhibitors. However, slow-binding inhibition according to mechanism A may
not be compatible with a fast-acting behavior on the steady-state time scale of a few seconds. We conclude that the
recruitment hypothesis (mechanism C) cannot account for slow phlorizin binding to the sodium-coupled glucose transport
protein(s), and that mechanism B is the only alternative that may explain the fast-acting slow-binding paradigm.
INTRODUCTION
Competitive inhibitors with specificity for a target protein
are useful probes of the kinetic mechanisms of enzyme-
catalyzed reactions and membrane transport processes. The
general approach to the study of such protein-inhibitor
interactions involves the analysis of the decrease in reaction
velocity that occurs in the presence of inhibitor as compared
to inhibitor-free control conditions. Alternatively, a more
direct approach relies on the interpretation of the kinetics of
inhibitor binding, usually measured using radiolabeled in-
hibitors in the presence of some or all of the physiological
effectors. In practice, the general approach has mostly been
restricted to enzyme reactions for which linear rates of
product formation can be measured on a time scale of
seconds to minutes in the absence of inhibitor (Morrison
and Walsh, 1988). By contrast, the direct approach has been
widely applied to a number of transport systems on the
rationale that the kinetic equations accounting for inhibitor
binding are usually simpler and easier to test than those
derived for substrate uptake because fewer carrier forms and
translocation steps need to be considered (Turner and Sil-
verman, 1980).
The current concepts describing the reversible interac-
tions between a competitive inhibitor (I) and its target
protein have been established within the context of steady-
state kinetics of unireactant enzymes (E). These theoretical
studies involved the analysis of an elementary reaction
scheme in which the formation of the enzyme–substrate
complex (ES) is rapid (rapid equilibrium assumption)
whereas the overall rate of catalysis is limited by the break-
down of this complex to form product (Morrison and Walsh,
1988). Accordingly, the reaction rate is linear over the time
period during which the initial rate assumptions are satisfied
(see Note 1). Competitive inhibitors for S are usually re-
ferred to as classical or slow-binding inhibitors, defined
where the rates of association with and dissociation from E
are fast or slow, respectively, relative to the reaction veloc-
ity (Morrison and Walsh, 1988). In the presence of classical
inhibitors, a steady-state concentration of EI is also rapidly
established and the initial rate remains linear, hence their
apparent fast-acting behavior. In contrast, the reaction rates
in the presence of slow-binding inhibitors demonstrate an
initial burst of high reaction rate followed by a slow de-
crease to a lower steady-state level. Two kinetic mecha-
nisms have been proposed that may account for slow-
binding inhibition (Morrison and Walsh, 1988). In
mechanism A, the inhibitor binding step itself represents the
overall rate-limiting step in the interaction because of bar-
riers that the inhibitor encounters when binding at the active
site of the enzyme. For mechanism B, it is assumed that
inhibitor binding involves the rapid formation of an initial
collision complex, but is followed by a slow isomerization
reaction. The burst kinetics described above thus reflect the
slow establishment of either the equilibrium between E, I,
and EI (mechanism A), or between the two enzyme-inhib-
itor complexes (mechanism B).
It should be emphasized that the distinction between
fast-acting and slow-binding inhibitors is in no way the
result of these mechanistic considerations (see Note 2) but
simply rests on the assumption that the two classes of
inhibitors can be identified through the application of
steady-state kinetic methods. Therefore, an obvious limita-
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tion to the steady-state formalism is that these methods may
fail to detect the occurrence of slow-binding inhibition if the
time required to achieve equilibrium binding is much larger
than the time period over which the initial rate assumptions
are satisfied (see Note 3). Such a limitation is particularly
relevant to membrane transport processes for which it may
prove difficult to record linear initial rates of transport using
isolated membrane preparations or cells for time periods in
excess of a few seconds (Berteloot and Semenza, 1990;
Chenu and Berteloot, 1993; Kimmich, 1990). This problem
is best illustrated by phlorizin, a reversible and highly
selective competitive inhibitor of the sodium-coupled glu-
cose transport (SGLT) systems of intestinal and renal tis-
sues, that is not transported by the SGLT proteins (Diedrich,
1966; Aronson, 1978; Semenza et al., 1984; Kimmich,
1990; Wright, 1993). Using a fast-sampling rapid-filtration
apparatus (Berteloot et al., 1991) and rabbit renal brush-
border membrane vesicles, our recent studies demonstrated
that the initial period during which glucose transport rates
are constant occurs on a time scale of 0–9 s in the presence
or absence of phlorizin (Oulianova and Berteloot, 1996).
According to the steady-state formalism, these results
should suffice to classify phlorizin as a fast-acting (classi-
cal) inhibitor, in which case, one would expect to observe
constant binding of labeled inhibitor over a time period
during which steady-state reaction rates are recorded (see
Note 4). This prediction clearly conflicts with the slow rates
of phlorizin binding usually reported using similar prepara-
tions, where up to 5 min incubation with radiolabeled phlo-
rizin may be required to reach equilibrium (Glossmann and
Neville, 1972; Chesney et al., 1974; Aronson, 1978; Turner
and Silverman, 1981; Koepsell et al., 1990). This situation
will be referred to as the fast-acting slow-binding paradigm
in the present paper.
The current hypothesis for the slow binding of phlorizin
is the recruitment concept (referred to as mechanism C in
this text), whereby the inhibitor is titrating a carrier confor-
mation in which a substrate binding site becomes accessible
to the inhibitor molecules (Aronson, 1978). More precisely,
it is proposed that the sugar (phlorizin) binding site on the
carrier has a predominant inward orientation, which is there-
fore shielded from access. A slow translocation (conforma-
tional change) to an outward-facing configuration would
then explain the slow kinetics of phlorizin binding to this
newly available site. To our knowledge, no theoretical jus-
tification has ever been provided to support the validity of
the recruitment concept, which rests primarily on circum-
stantial pieces of evidence (Aronson, 1978; Toggenburger
et al., 1978, 1982; Turner and Silverman, 1981; Restrepo
and Kimmich, 1986). Moreover, the kinetics of phlorizin
binding have never been considered with regard to the
applicability of mechanisms A and B discussed above. In
this respect, it should be noted that the early studies of
Turner and Silverman (1980) were only concerned with the
kinetics of inhibitor binding at equilibrium. Because all of
mechanisms A–C above predict Scatchard-like kinetics rel-
ative to inhibitor concentrations under these conditions, this
approach does not provide the information that allows us to
assess which of these models might explain the fast-acting
slow-binding paradigm.
The present studies are aimed at deriving kinetic equa-
tions that may best characterize inhibitor binding conform-
ing to each of mechanisms A–C. The proposed theoretical
approach takes on a quite general significance and involves
models of arbitrary dimension on the rationale that realistic
transport and enzyme mechanisms are usually more com-
plex than the elementary reaction schemes used by Morri-
son and Walsh (1988) to describe the steady-state approach.
Moreover, because the limitations associated with the
steady-state formalism to assess inhibitor binding mecha-
nisms apply to both transport processes (see Note 3) and
enzyme reactions (Morrison and Walsh, 1988), the question
of protein-inhibitor interactions is addressed with regard to
the direct measurement of inhibitor binding to a protein. We
therefore assume throughout this paper: 1) that an adequate
assay has been found to measure, in a time-dependent way,
the fraction of inhibitor bound to the relevant protein-
inhibitor complexes, 2) that the progress of inhibitor bind-
ing can be satisfactorily described at the experimental level
by a monoexponential function, and 3) that the binding data
to be analyzed have been adequately corrected for nonspe-
cific binding. Using this formalism, it is demonstrated that
each of mechanisms A–C can be readily identified accord-
ing to the position of the inhibitor binding step relative to
the rate-limiting step in the inhibitor binding sequence. This
key structural feature is the main determinant of unique
kinetic properties that should allow anyone to determine
unambiguously whether the inhibitor binding step either (A)
represents, (B) precedes, or (C) follows the rate-limiting
step. It is further shown that the relevance of mechanism C
to slow-binding inhibition is conditioned by the turnover
rate of the catalytic cycle under symmetrical conditions, and
that mechanism B represents the only alternative to explain
the fast-acting slow-binding paradigm of phlorizin.
MATERIALS AND METHODS
Time scale separation hypothesis and
basic model
To reduce the complexity of the mathematics involved in deriving the
characteristic equations for models of arbitrary dimension, it is appropriate
to introduce approximations based on the principle that some reaction steps
are faster than others, so that the time course of inhibitor binding to be
observed will be governed by the slowest steps (Wierzbicki et al., 1990).
In the following, we limit our analyses to the case where the progress of
inhibitor binding can be satisfactorily described at the experimental level
by a monoexponential function. This simplifying assumption allows us to
compare our results with those of the steady-state approach pioneered by
Morrison and Walsh (1988).
The kinetic mechanism shown in Fig. 1 A represents the simplest
scheme that satisfies the above requirements, and the question of its
relevance to more realistic kinetic mechanisms will be addressed in the
Discussion. This model assumes that the binding of an arbitrary number of
Ai effector molecules to a protein N can be described by a linear array of
elementary reactions among which a slow isomerization (conformational
change) with rate constants kon and koff represents the only rate-limiting
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step within the reaction sequence. This hypothesis is equivalent to stating
that all the rate constants governing the association and dissociation of the
Ai effectors with the protein are fast compared to kon and koff. Therefore, it
is possible to define two blocks of elementary reactions called X and Y, in
which all the chemical species can be considered to be in equilibrium with
each other (rapid equilibrium assumption) both before and during the
time-dependent slow interconversion between blocks X and Y (Cha, 1968;
Wierzbicki et al., 1990). This, in turn, allows us to introduce the dissoci-
ation constants Ki
X and Ki
Y to describe each of the Ai binding steps within
blocks X and Y, respectively. Note that the inhibitor binding step has not
been included at this stage of the analysis to initially establish the most
general solution describing the time-dependent interconversion (relaxation)
between blocks X and Y, and to avoid redundancy in the derivation of more
specific solutions applying to the different mechanisms of inhibitor bind-
ing, which will be considered later.
Time-dependent solution of the basic model
In the following, it is postulated that the concentrations of all of the Ai
effectors present in the incubation media are constant over time and
represent their total concentrations. For simplicity at this point, one may
assume that none of the Ai effectors in the X and Y blocks is a substrate
involved in a catalytic process, a hypothesis that will be relaxed in the
Discussion.
According to Cha’s rules (Cha, 1968), the general scheme depicted in
Fig. 1 A can be reduced to its equivalent form shown in Fig. 1 B where the
apparent rate constants k*on and k*off are defined as
k*on kon f p
X , (1)
k*off koff f 1
Y , (2)
and now replace the true rate constants kon and koff. The latter are weighted
by the factors f p
X and f 1
Y, whose mathematical expressions,
f p
X
Np
X
X

Np
X

i1
p Ni
X
, (3)
f 1
Y
N1
Y
Y

N1
Y

i1
q Ni
Y
, (4)
clearly indicate that they represent the fractional concentrations of the
chemical species Np
X and N1
Y within blocks X and Y, respectively. The
denominators of Eqs. 3 and 4 can be expressed relative to the Np
X and N1
Y
species as
X Np
X1 LX, (5)
Y N1
Y1 LY, (6)
where algebraic expressions of the quantities LX and LY
LX 
i1
p1 
ji
p1 Kj
X
Aj
X , (7)
LY 
i1
q1 
j1
i Aj
Y
Kj
Y , (8)
are conditioned by the rapid equilibrium assumption. Note that the two
blocks, X and Y, are also linked through the conservation equation,
NT X Y. (9)
The time-dependent interconversion between blocks X and Y can be
described by the differential equation
dY
dt

dX
dt
 konNp
X koffN1
Y k*onX k*offY, (10)
FIGURE 1 Basic model used for detailed kinetic analyses. (A) The structure of the basic model is composed of a linear array of elementary reactions,
only one of which may be considered to be rate-limiting for the relaxation process with association and dissociation rate constants kon and koff, respectively.
All the other reactions thus satisfy the rapid equilibrium assumption, which allows us to define the two blocks of elementary reactions X and Y. The Ni
species may represent any protein under its free form (N1) or following complexation with Ai effectors, each complex formation being described by a
dissociation constant Ki. (B) Reduced basic model according to Cha’s formalism (Cha, 1968) in which the apparent rate constants k*on and k*off defined in
Eqs. 1 and 2 in the text now replace the true rate constants kon and koff.
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in which the right-hand-side expression results from the consideration of
Eqs. 3–6 and can be transformed as
dY
dt
 k*on NT k*on k*offY, (11)
by incorporating Eq. 9. Equation 11 can be further rearranged as
dY
dt
 kobsY kobsYe , (12)
with the definitions for kobs (apparent first-order rate of the relaxation
process)
kobs k*on k*off , (13)
and Ye (equilibrium concentration of Y at the end of the relaxation process),
Ye
k*on NT
kobs
. (14)
The integration of Eq. 12 over time is straightforward and leads to equiv-
alent monoexponential functions
Y Ye Ye Y0e
kobst
 Y0 Ye Y01 ekobst, (15)
in which Y0 represents the zero-time concentration of Y at the start of the
relaxation. Note that the evaluation of Y0 shall depend on the specific
kinetic mechanisms to be considered later. A last quantity that may be
measured experimentally is the initial rate of interconversion (Yi), the
mathematical expression of which can be readily obtained from the first
derivative of Eq. 15 at t  0, as
Yi ⎣dYdt ⎦t0 kobsYe Y0. (16)
Note that Eq. 10 could have been made homogeneous relative to X to
describe the same phenomenon with the differential equation
dX
dt
 k*off NT k*on k*offX (17)
as a result, the integration of which leads to
X X0 Xe X01 ekobst, (18)
where the quantity X0 (zero-time concentration of X) should reflect the
boundary conditions applying to each specific mechanism while Xe
(equilibrium concentration of X) represents the solution of Eq. 17 when
dX/dt  0,
Xe
k*off NT
kobs

k*off Ye
k*on
. (19)
Inhibitor-binding mechanisms and
further assumptions
If inhibitor binding is now considered in the kinetic schemes shown in Fig.
1, it is readily apparent that only three possibilities may be viewed whereby
the inhibitor binding step either represents (mechanism A), precedes
(mechanism B) or follows (mechanism C) the rate-limiting step. As de-
picted in Fig. 2, these three mechanisms are associated with the assump-
tions 1) there is only one inhibitor binding site, so that inhibitor binding at
equilibrium should conform to Scatchard kinetics relative to the free
concentration of inhibitor [I], 2) the inhibitor binding site is accessible
through only one of the Ni species, and 3) the total concentration of
inhibitor (IT) far exceeds the total concentration of binding sites (NT), so
that [I]  IT and [I] can be considered constant during the time interval
over which the binding assay is performed. Note that the relaxation of
assumptions 1 and 2 will be considered in the Discussion whereas assump-
tion 3 excludes from consideration the so-called tight-binding inhibitors for
which there is not a single rate equation for the time course, but rather a
pair of parametric equations that describe the progress curves at different
inhibitor concentrations (Sculley et al., 1996). Also, with the current
hypothesis that none of the Ai effectors is a substrate involved in a catalytic
process, mechanisms A–C in Fig. 2 are quite general and may describe the
kinetics of inhibitor (or any other molecule) binding to any protein inde-
pendent of the time scale of the observation, which is conditioned by the
nature of the binding assay and limited by the absolute values of k*on and
k*off. The question of the applicability of mechanisms A–C to fast-acting
and slow-binding inhibitions is addressed in the Discussion.
The formalism previously discussed and justified by Wierzbicki et al.
(1990) for presteady-state kinetics can now be used to identify time-
dependent solutions of inhibitor binding provided that the following as-
sumptions, with regard to the conditions of the binding assays, are intro-
duced. We first assume that the relevant preparations to be tested for
inhibitor binding have been sufficiently resuspended in the uptake media to
ensure that true equilibrium conditions have been reached with each of the
Ai effector molecules at the time of the assay, so that it is possible to
calculate the boundary conditions (X00 and Y00) prevailing before the start
of the binding assay. We next assume that the binding assay is started by
mixing the above preparations in identical media containing the inhibitor to
be tested, so that there will be fast redistribution only of those Ni
X or Ni
Y
species involved in rapid equilibrium reactions with the inhibitor. Accord-
ingly, it is possible to calculate the boundary conditions (X0 and Y0)
prevailing at the very start of the relaxation process when t  0. Finally,
because, in mechanisms B and C, the rates of association and dissociation
of the inhibitor are fast compared to k*on and k*off, one may also need to
consider that some binding assays, including the rapid filtration technique,
may fail to detect most (if not all) of the inhibitor molecules bound to the
Ni
X or Ni
Y species in each of these models, respectively.
To avoid redundancy in the writing of both similar equations and the
definitions of similar parameters, reference is made throughout the text to
the Scatchard or Michaelis–Menten equation
B
BmaxI
Kd I
, (20)
in which B represents the amount of inhibitor molecules bound to its
specific site on the protein, (I) stands for the free concentration of inhibitor
(but I  IT, see above)), and Bmax (apparent maximum number of binding
sites) and Kd (apparent dissociation constant for inhibitor binding) are the
usual kinetic parameters of interest to be determined. The indices 0, i, and
e associated with these parameters consistently represent the kinetic situ-
ation that prevails, respectively, at the very start of the binding assay when
t  0, over the time period during which it can be assumed that true initial
rates of binding can be measured, and at equilibrium when a steady-state
plateau value has been reached. When necessary, the kinetic parameter
KXY
koff
kon
(21)
is introduced, which represents the dissociation constant characterizing the
rate limiting step. Note that KXY  Kd (intrinsic dissociation constant for
inhibitor binding) in mechanism A only.
All calculations involving complex algebraic expressions have been
performed using Mathematica software for Windows. For the more specific
cases discussed in the Appendix, the initial velocity equations and the
relevant distribution equations are derived using computer calculations
described elsewhere (Falk et al., 1998).
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RESULTS
Mechanism A: Inhibitor binding is the
rate-limiting step
To solve mechanism A, the basic model depicted in Fig. 1 A
only needs to be modified to include inhibitor binding to the
Np
X species as shown, under reduced form, in Fig. 2 A.
Accordingly, Eqs. 2–9 still apply to this model while a
correct expression for k*on should now read as follows.
k*on kon f p
XI. (22)
Moreover, because all the Ni species in block Y contribute to
the binding equation, the time course of inhibitor binding
will be described by Eq. 15 in which B is substituted for Y,
and kobs is given by Eq. 13. The boundary conditions
X00 X0 NT; Y00 Y0 B0 0 (23)
are easily established from our assumptions regarding the
binding assay conditions (see the section entitled “Inhibitor-
binding mechanisms and further assumptions” under Mate-
rials and Methods). The quantities Be  Ye and Bi  Yi can
also be found from proper substitution into Eq. 14 and 16,
respectively. A few arithmetic manipulations using the rel-
evant equations above are necessary to derive the algebraic
expressions of the different kinetic parameters shown in
Tables 1 and 2.
Mechanism B: Binding of the inhibitor precedes
the rate-limiting step
General considerations
The analysis of mechanism B requires an expansion of the
basic model depicted in Fig. 1 A to include an inhibitor
binding step within the X block. The resulting reduced
scheme is shown in Fig. 2 B, from which the boundary
conditions appear similar to those previously established for
mechanism A (Eq. 23). Eqs. 2, 4, 6, and 8, which all apply
FIGURE 2 The three kinetic mechanisms that may account for slow inhibitor binding. (A) Extension to a dimensionless model of previous mechanism
A (Morrison and Walsh, 1988), in which inhibitor binding may itself represent the rate-limiting step. (B) Extension to a dimensionless model of previous
mechanism B (Morrison and Walsh, 1988), in which fast inhibitor binding with dissociation constant Kd is followed by a slow isomerization step. Before
inhibitor addition, all the Ni species are constrained within subblock X1, so that X00  X1  NT. Once added, the inhibitor promotes fast redistribution of
the Ni
X1 species between subblocks X1 and X2, forming the new X block, so that X0 NT. The relaxation process between blocks X and Y follows thereafter.
(C) Application to a dimensionless model of the recruitment hypothesis (Aronson, 1978; Turner and Silverman, 1980), in which a slow conformational
change controls the rate of inhibitor binding with dissociation constant Kd. Before inhibitor binding, there is a true equilibrium between block X and
subblock Y1. Once added, the inhibitor promotes fast redistribution of the Ni
Y1 species between subblocks Y1 and Y2, forming the new Y block, and the
relaxation process between blocks X and Y follows thereafter. When not given in details in mechanisms A–C, the structure of the elementary reactions
occurring in blocks X and Y is identical to that shown in Fig. 1 A. The apparent rate constants k*on and k*off are defined by Eqs. 1 and 2 in the text except
for mechanism A, in which Eq. 22 should be substituted for Eq. 1.
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to the Y block, are still valid as shown in this particular case,
hence the algebraic expression of k*off shown in Table 1.
Similarly, Eqs. 1 and 3 referring to block X still hold;
however, Eq. 5 needs to be rewritten as
X Np
X1 L2X  KdI1 L1X, (24)
to account for the inhibitor binding step. The algebraic
expression of k*on appearing in Table 1 follows from these
considerations whereas those of the new parameters appear-
ing in Eq. 24 are as
L2
X 
ik1
p1 
ji
p1 Kj
X
Aj
X , (25)
  
jk1
p1 Kj
X
Aj
X , (26)
L1
X 
i1
k1 
ji
k1 Kj
X
Aj
X . (27)
At this stage in the analysis of mechanism B, it is impor-
tant to question to what extent the inhibitor-bound Ni
X(BX
X2) and Ni
Y(BY  Y) species contribute to the binding
equation, B BX BY, in actual experiments. Indeed, most
(if not all) of the inhibitor molecules bound to the Ni
X
species might be lost in any binding assay involving a
TABLE 1 Kinetic characteristics of the three mechanisms of inhibitor binding depicted in Fig. 2
Experimental
Parameters
Kinetic Mechanisms
A B occluded B general C
B0 0 0
Bmax0I
Kd0 I
Bmax0I
Kd0 I
Bi
konNTI
1 LX
BmaxiI
Kdi I
BmaxiKdiI
Kdi I	
2
BmaxiI
2
Kdi I	
2
Be
BmaxeI
Kde I
BmaxeI
Kde I
BmaxeI
Kde I
k*on
konI
1 LX
konI
Kd1 L1
X 1 L2
XI
kon
1 LX
k*off
koff
1 LY
koff
1 LY
koffKd
Kd1 L1
Y I1 L2
Y
kobs linear increase hyperbolic increase hyperbolic decrease
The experimental parameters are defined relative to a family of progress curves generated at different concentrations of the inhibitor as follows: B0,
zero-time intercept; Bi, initial rate of binding; Be, equilibrium binding; k*on and k*off, apparent first-order rates of inhibitor association to and dissociation
from the protein; kobs, apparent first-order rate of the relaxation process as given by Eq. 13. Bmax0, Bmaxi, Bmaxe, Kd0, Kdi, and Kde represent the usual kinetic
parameters of interest to be determined, and their algebraic expressions are reported in Table 2. All the other constants are defined in the text.
TABLE 2 Algebraic expressions of the kinetic parameters appearing in the equations reported in Table 1
Kinetic
Parameters
Kinetic Mechanisms
A B occluded B general C
Bmax 0 0 NT
1 L1
YNT
1 L1
Y KXY1 LX
Kd0 0 0
1 L1
XKd
1 L2
X
1 L1
YKd
1 L2
Y
Bmaxi —
konNT
1 L2
X
konKXYNT
1 L1
Y KXY1 LX
Kdi —
1 L1
XKd
1 L2
X  Kd0
1 L1
YKd
1 L2
Y
 Kd0
Bmaxe NT
1 LYNT
1 LY KXY1 L2
X
NT NT
Kde
1 LXKd
1 LY
KXY1 L1
XKd
1 LY KXY1 L2
X
1 L1
Y KXY1 LX	Kd
1 L2
Y
All the constants appearing in the algebraic expressions shown are defined in the text.
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quench technique to stop the reaction, because the time
scale separation hypothesis clearly states that all the disso-
ciation rates associated with the inhibitor-bound Ni
X species
are fast as compared to k*off (see also the sections entitled
“Time scale separation hypothesis and basic model” and
“Inhibitor-binding mechanisms and further assumptions”
under Materials and Methods). In contrast, as in mechanism
A, the inhibitor bound Ni
Y species would appear as occluded
under these conditions in that the inhibitor molecules bound
to these species are shielded by the rate-limiting step from
free exchange with the external milieu.
The binding equation involves the Ni
Y species only: The
occlusion case
From the above description, it is readily apparent that a
situation in which BX  0 can be favored in a radiotracer
assay, either voluntarily or not, by including a saturating
concentration of the unlabeled inhibitor (or a competitive
substrate or effector) in the quench solution. In this case, the
time course of inhibitor binding will be described by Eq. 15,
in which BY is substituted for Y, kobs is given by Eq. 13, and
B0
Y  0 (Eq. 23). Similarly, the quantities Be
Y  Ye and
Bi
Y  Yi can be obtained from proper substitution into Eq.
14 and 16, respectively. A few arithmetic manipulations
using the relevant equations above are necessary to get the
algebraic expressions of the different kinetic parameters
shown in Tables 1 and 2. It can be further demonstrated that
the relationship
Kde
Kdi

Bmaxi
Y
Bmaxe
Y 
koff
1 LY
 k*off (28)
applies, thus providing an internal consistency test of the
model.
The binding equation involves both the Ni
X and Ni
Y species:
The general case
If all of the inhibitor-bound species can be detected in the
assay, then the binding function should also include the BX
term, which can be expressed relative to Np
X, as
BX X2 
ik1
p
Ni
X 1 L2
XNp
X , (29)
when accounting for the rapid equilibrium assumption. It is
thus possible to calculate the fractional concentration of the
chemical species to which the inhibitor is bound in the X
block ( f b
X) by combining Eqs. 24 and 29 as
f b
X
BX
X

1 L2
XI
Kd1 L1
X 1 L2
XI
. (30)
Because the latter equation holds true at both t  0 and at
equilibrium (see the section “Inhibitor-binding mechanisms
and further assumptions” under Materials and Methods), the
time-dependent relaxation of BX will be described by the
quantity f b
XX, in which X is given by Eq. 18. The quantity
Be
X  f b
XXe (number of binding sites in block X at equilib-
rium) can be computed from Eq. 19 and rearranged under
the Scatchard form,
Be
X
Bmaxe
X I
Kde I
where
Bmaxe
X 
KXY1 L2
XNT
1 LY KXY1 L2
X
 NT , (31)
in which the algebraic expression of Kde is identical to that
previously established in the occluded case (Table 2). Sim-
ilarly, the quantity B0  f b
XX0 (initial binding at t  0) can
be found using the boundary conditions given by Eq. 23 and
cast under the Scatchard form shown in Table 1, with
algebraic expressions of the kinetic parameters as reported
in Table 2. Note that Kd0 in the general case is equal to Kdi
in the occluded case, and that the quantity
Be
X Bo

1 LYNTI2
1 LY KXY1 L2
X	Kdi I	Kde I	
(32)
has a negative sign, indicating that the number of inhibitor
molecules bound to the block X species decreases with time.
It is now possible to derive the time-dependent equation
that describes the kinetics of inhibitor binding B by sum-
ming up the two exponential functions BX and BY. The final
result is similar in form to Eq. 15, but where B is substituted
for Y, with B0 already given in Tables 1 and 2 and the
quantity Be  Be
X  Be
Y calculated from Table 2 and Eq. 31.
Note that Be is the sum of two Scatchard equations with
identical denominators, so that the relationship Bmaxe 
Bmaxe
X  Bmaxe
Y  NT can be readily established. Similarly,
a correct expression of Bi can be computed from Eq. 16 with
proper substitutions therein, and a few arithmetic calcula-
tions show that Bi can be cast under the generic form shown
in Table 1 with algebraic expressions of Bmaxi and Kdi as
given in Table 2. Accordingly, at increasing concentrations
of the inhibitor, the initial rate data should first increase to
reach a maximum value equivalent to Bmaxi/4 when (I) 
Kdi and decrease toward zero thereafter.
Mechanism C: Binding of the inhibitor follows the
rate-limiting step
To solve this kinetic mechanism, the basic scheme depicted
in Fig. 1 A also needs to be expanded to include an inhib-
itor-binding step within the Y block as shown in Fig. 2 C.
Note that the Y2 block, which represents the fraction of
inhibitor molecules bound to the Ni
Y species, is not protected
from free exchange with the external milieu in this partic-
ular case. Therefore, inhibitor binding may not be measur-
able using a radiotracer technique in combination with a
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rapid filtration assay. Subject to this experimental limita-
tion, the following theoretical considerations are neverthe-
less right.
Eqs. 1, 3, 5, and 7, which all apply to the X block, are still
valid as shown in this case, hence the algebraic expression
of k*on appearing in Table 1. Similarly, Eqs. 2 and 4, refer-
ring to the Y block, still hold; however, Eq. 6 needs to be
rewritten as
Y N1
Y1 L1Y  IKd1 L2Y (33)
to account for the inhibitor binding step. The algebraic
expression of k*off appearing in Table 1 follows from these
considerations, whereas those of the new parameters ap-
pearing in Eq. 33 are given as
L1
Y 
i1
k1 
j1
i Aj
Y
Kj
Y , (34)
  
j1
k1 Aj
Y
Kj
Y , (35)
L2
Y 
ik1
q1 
jk1
i Aj
Y
Kj
Y . (36)
In this model, the binding function,
B Y2 
ik1
q
Ni
Y 
I
Kd
1 L2
YN1
Y , (37)
and the fractional concentration of the chemical species to
which the inhibitor is bound in the Y block,
f b
Y
B
Y

I1 L2
Y
Kd1 L1
Y I1 L2
Y
, (38)
can be readily written from a visual inspection of Fig. 2 C.
Because the latter relationships hold true at both t  0
(when B0  f b
YY0) and equilibrium (when Be  f b
YYe), the
time course of inhibitor binding should thus be described by
Eq. 15, in which B is substituted for Y, kobs is given by Eq.
13, and the quantity Be found from proper substitution into
Eq. 14. A few arithmetic manipulations are necessary to get
the algebraic expressions of the kinetic parameters shown in
Table 2. A correct expression of Bi can be derived from Eq.
16 as
Bi kobs f b
YYe Yo kobsBe Bo. (39)
One thus needs to define the boundary conditions to deter-
mine the algebraic expression of the initial rate of binding.
This is done as follows. Because there is a true equilibrium
between the block X ( X00) and the subblock Y1 ( Y00)
before addition of the inhibitor (see the section “Inhibitor-
binding mechanisms and further assumptions” under Mate-
rials and Methods), it is possible to write down the set of
equations,
X00 Y00 NT , (40)
k*onX00 k*off Y00 . (41)
When solved in conjunction with Eqs. 1–5 and 33 (in which
[I]  0 before the start of the experiment), the algebraic
expression,
Y00
NT1 L1
Y
1 L1
Y KXY1 LX
, (42)
can be obtained following a few arithmetic manipulations.
Because Y0  Y00 in this particular case (see the section
“Inhibitor-binding mechanisms and further assumptions”
under Materials and Methods), then Bo f b
YY00 with f b
Y and
Y00 as given by Eqs. 38 and 42, respectively. B0 can be cast
under the Scatchard form given in Table 1 with algebraic
expressions of the kinetic parameters as reported in Table 2.
The initial rate of binding can now be calculated from Eq.
39 and proper substitutions therein. Bi can be cast under the
generic form shown in Table 1 with algebraic expressions of
Bmaxi and Kdi as given in Table 2. The Bi versus [I] plot
should clearly deviate from simple Scatchard kinetics, and
the apparent Hill number value (nH) that one may expect
from a Hill plot analysis of the initial rate data can be
estimated from the relationship
nH d LnBi/Bmaxi Bi	d LnI 
(I)0.5
  BmaxiIBiBmaxi Bi  dBidI(I)0.5 , (43)
which was previously derived from a similar equation (Falk
et al., 1998). The (I)0.5 expression,
I0.5 Kdo1 2, (44)
can be found by solving the Bi equation in Table 1 for (I)
after setting Bi  Bmaxi/2, whereas the formal development
of the terms in brackets at the right-hand-side of Eq. 43
leads to
nH 1
Kdo
Kdo 2I0.5
, (45)
and then to nH  1.17 when Eqs. 44 and 45 are combined.
Accordingly, the sigmoidicity predicted in the Bi versus [I]
plot may not be easily detected at the experimental level,
particularly because the inflexion point occurs in the very
early part of the curve when (I)  Kdo/2.
DISCUSSION
Kinetic criteria aimed at model discrimination
The results presented in these studies clearly demonstrate
that the three basic mechanisms of inhibitor binding de-
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picted in Fig. 2 are associated with a set of kinetic features
which could be easily investigated at the experimental level
by the analysis of a family of binding time courses gener-
ated at different concentrations of the inhibitor as follows
1. As shown in Table 1, all curves should either go through
the origin [mechanisms A and B (occluded)] or intercept
the y axis at discrete B0 values [mechanisms B (general)
and C]. In the latter situation, a B0 versus (I) plot should
demonstrate Scatchard kinetics from which either the
total [mechanisms B (general)] or apparent (mechanism
C) number of binding sites, and the initial apparent
dissociation constant for inhibitor binding (Kd0) can be
determined (Table 2).
2. The initial rate of binding (Bi in Table 1) should saturate
at increasing inhibitor concentrations in mechanisms B
(occluded) and C. For the latter, the binding data deviates
from simple Scatchard kinetics (note that it might prove
difficult to detect the sigmoidicity of the Bi versus [I]
plot at the experimental level, see Eqs. 43–45), and the
Kdi value estimated from its kinetic analysis should be
identical to the Kd0 value. In contrast, Bi should increase
linearly with [I] in mechanism A, and so, the initial rate
data might be mistakenly thought to represent nonspe-
cific binding. In mechanism B (general) too, the Bi
versus [I] plot deviates from simple Scatchard kinetics
and the data curve first increases to a maximum value
and then decreases toward 0.
3. When the inhibitor binding step either precedes (mech-
anism B) or itself represents (mechanism A) the rate-
limiting step, the k*on value only, and not the k*off, is
affected by [I], whereas the reverse situation holds true
in mechanism C, where the inhibitor binds downstream
of the rate-limiting step (Table 1). Consequently, accord-
ing to Eq. 13, kobs should linearly increase and hyper-
bolically decrease in mechanisms A and C, respectively.
In contrast, mechanism B predicts a Scatchard-like de-
pendence of the kobs versus [I] plot with an intercept
value on the y axis representing the apparent first-order
rate for dissociation of the inhibitor. Note that the alge-
braic expression of k*on in Table 1 can be further rear-
ranged as
k*on
kon
maxI
Kdi I
, (46)
where
kon
max
kon
1 L2
X
Bmaxi
NT
, (47)
to demonstrate that the half-saturation of kobs is achieved
when [I]  Kdi (occluded case)  Kd0 (general case),
thus providing an internal test of mechanism B. A similar
rearrangement of the algebraic expression of k*off for
mechanism C in Table 1 could be performed to show that
the value of this parameter is reduced by half at [I]  Kd0.
4. As expected from the assumption that there is only one
inhibitor binding site, the Be versus [I] plot should sat-
urate for all mechanisms, and a Scatchard analysis of the
equilibrium data should allow one to determine the ap-
parent dissociation constant of the inhibitor and the total
number of binding sites except for mechanism B (oc-
cluded) in which Bmaxe
 NT (Table 2). In the latter case,
NT can only be calculated, and this is easily done using
Eq. 47. A comparison of the algebraic expressions of Kde
and of either Kdi or Kd0, shown in Table 2 for mechanism
B, allows us to establish,
Kde
Kdi

KXY1 L2
X
1 LY KXY1 L2
X
 1, (48)
that the apparent affinity for inhibitor binding estimated
at equilibrium should always be higher than that ob-
served during the initial phase of binding. In contrast, the
relationship
Kde
Kdo
 1 KXY
1 LX
1 L1
Y 1 (49)
is always predicted in the case of mechanism C. It can be
concluded that the value of the Kde/Kdi ratio is deter-
mined by kinetic properties that appear intrinsic to mech-
anisms B and C, so that this parameter takes on particular
relevance for model discrimination.
Among these kinetic features, the dependence on inhibi-
tor concentration of the apparent first-order rate of binding
kobs appears to be the most reliable indicator for diagnostic
purposes. Its analysis should thus allow one to establish
unambiguously whether the inhibitor binding step itself or a
step that either precedes or follows inhibitor binding repre-
sents the overall rate-limiting step in a binding process.
However, this conclusion raises the question of the predic-
tive value of the basic schemes shown in Figs. 1 and 2 when
applied to more complex models and to transport mecha-
nisms in particular.
Validity of the predictions of the basic scheme
with regard to more complex models and
transport mechanisms
It could be argued that the simplistic nature of the basic
models depicted in Figs. 1 and 2 may restrict the validity of
our studies to just a few realistic kinetic mechanisms. This
argument is refuted below, where it clearly appears that our
results are, in fact, conditioned by the structure of the
reduced kinetic scheme shown in Fig. 1 B.
Equations similar in form to Eqs. 5 and 6 can be derived
for any kinetic mechanism to which the rapid equilibrium
assumption applies. This assertion follows from Cha’s rule,
stating that, when there is more than one pathway through
which Ni may be converted to Nj in a rapid equilibrium
segment, any one and only one of these pathways may be
used for the evaluation of Nj relative to Ni (Cha, 1968).
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Accordingly, either one or both of the X and Y blocks shown
in Fig. 1 B could include any number of cycles, random
sequences of effector addition, and/or branched pathways.
In addition, the rate-limiting step linking these two blocks
could involve any of the Ni
X and/or Ni
Y species. In such
cases, the algebraic expressions of LX and LY might be more
complex than those shown in Eqs. 7 and 8 and include both
Kj/Aj and Aj/Kj terms for those effector molecules which,
respectively, dissociate from or associate with the Ni
X and/or
Ni
Y species linking the two blocks. Accordingly, it can be
predicted that low upstream or high downstream effector
concentrations relative to location of Ni
X would both act to
decrease the apparent value of kobs (increase the time con-
stant of the relaxation process). Such a situation has been
described for the slow binding of 3H-ouabain to Na,K-
ATPase, which was found to be accelerated by Na and
retarded by K, thus suggesting that Na and K modulate
glycoside interaction through an induction (Na) or repres-
sion (K) of the macromolecular conformation appropriate
for glycoside binding (Schwartz et al., 1974). In this par-
ticular case, the inhibitor binding step itself represents the
rate-limiting step of the ouabain binding process, a conclu-
sion that was reached on the ground that kobs increases
linearly with glycoside concentrations, in agreement with
the results of our studies using the basic model shown in
Fig. 2 A.
More complex situations could arise if rate-limiting steps
exist within cycles as may occur in transport mechanisms
(see examples given in the Appendix) and other kinetic
mechanisms showing random sequences of effector and/or
inhibitor addition. In such cases, the predictive value of the
basic models depicted in Fig. 2 will not be affected provided
that:
1. the rate-limiting steps isolate two clearly identifiable
blocks. This condition is essential for applying the rule
of additivity of parallel pathways proposed by Volken-
stein and Goldstein (1966), which would allow one to
reduce the kinetic mechanism to a scheme similar in
form to that shown in Fig. 1 B. Because this rule is not
restrictive as to the number of rate-limiting steps con-
necting the two blocks, the expressions,
k*on 
i1
n
k*oni 
i1
n
koni f i
X , (50)
k*off 
i1
n
k*offi 
i1
n
koffi f i
Y , (51)
in which n represents the number of rate-limiting steps
with rate constants (kon)i and (koff)i, only need to be
substituted for Eqs. 1 and 2, respectively. Note that all
the f i
X or f i
Y fractions characterizing the Ni species in-
volved in the relaxation process have identical denomi-
nators (Cha, 1968), so that their summation does not
introduce [I]2 terms.
2. all rate-limiting steps involve inhibitor binding, in which
case the kinetic mechanism can be reduced to a scheme
similar in form to that shown for mechanism A in Fig. 2,
where the k*on expression,
k*on 
i1
n
koni f i
XI I
i1
n
koni f i
X , (52)
only needs to be substituted for Eq. 22. Alternatively, the
inhibitor molecule may bind either upstream or down-
stream of the rate-limiting steps, in which case the cor-
responding kinetic mechanisms can be reduced to
schemes similar in form to those shown for mechanisms
B and C in Fig. 2, respectively. Clearly, then, all of these
situations would preserve the predictive value of kobs for
discrimination between mechanisms A and C (Table 1).
Note that the failure to satisfy condition 1 should result in
binding time courses showing more than one relaxation
constant; however, the Be versus [I] plot should still con-
form to Scatchard kinetics if only one inhibitor binding site
is involved. Also, the failure to satisfy condition 2 should
lead to a situation where the kobs versus [I] plot is more
complex than predicted in spite of both monoexponential
binding kinetics and of Be versus [I] plots conforming to
Scatchard kinetics.
Finally, Cha’s rule and the additivity principle above may
be combined (Cha, 1968) to reduce almost any kinetic
mechanism to the basic structure shown in Fig. 1 B provided
that our hypotheses (see Materials and Methods) and the
restrictions discussed above are respected. Thus, equations
similar in form to Eqs. 24 and 33 may be derived for kinetic
mechanisms in which the inhibitor binds to more than one
of the Ni species involved in blocks X or Y. Because our
analysis was restricted to the case of one inhibitor binding
site only, this would preclude [I]2 terms in the above equa-
tions under rapid equilibrium conditions. However, should
there be more than one binding site in block X or Y, the
predictive value of kobs would be preserved: this parameter
should still decrease or increase with the concentration of
inhibitor in models B or C, respectively. Such mechanisms
may then be recognized from the non-Scatchard dependence
of the Be versus [I] plot.
Relevance of mechanisms A–C to fast-acting
(classical) inhibitors and
monoexponential kinetics
As noted earlier, fast-acting or slow-binding inhibition is
not the result of mechanistic considerations but rests on the
assumption that the two classes of inhibitors can be identi-
fied through the application of steady-state kinetic methods,
i.e., on the time scale of seconds to minutes. However, our
hypothesis that the kinetics of inhibitor binding can be
described by monoexponential functions at the experimental
level does not set any limit on the time scale over which this
observation is made because the scale is dictated by the
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absolute values of k*on and k*off. Therefore, mechanisms A–C
in Fig. 2 could all apply to fast-acting inhibitors provided
that the binding assay can resolve the kinetics of inhibitor
binding on the presteady-state time scale. Over this subsec-
ond time range, the condition that none of the Ai effectors is
a substrate or product involved in a catalytic process could
even be relaxed, so that these three mechanisms could also
be used to analyze the presteady-state kinetics of transport
processes or enzyme reactions according to the simplified
approach proposed by our group (see Note 5) (Wierzbicki et
al., 1990). For example, as was justified for a four-state
model of carrier-mediated transport, two rate-limiting steps
need to be considered to allow for monoexponential kinet-
ics, and six submodels would satisfy this condition. Accord-
ingly, the formalism described in the present paper may also
be used to reduce all of these submodels to the general
scheme shown in Fig. 1 B, so that the algebraic expression
of the apparent first-order rate characterizing the relaxation
process in each can now be readily obtained from the
consideration of Eqs. 13 and 50–52. Indeed, this new ap-
proach leads to results that are identical to those reported by
Wierzbicki et al. (1990) in his Table 4 (see Note 6). More-
over, as predicted in Table 1, kobs assumes either a Michae-
lis–Menten or a linear dependence on substrate concentra-
tions for those submodels in which, respectively, the rapid
equilibrium addition of substrate induces the relaxation
process (models 1, 2, and 4) or the substrate addition step
itself represents the rate-limiting step (models 3, 5, and 6).
Relevance of mechanisms A and B to
slow-binding inhibitors
The parallelism between mechanisms A and B shown in
Fig. 2 and their elementary counterparts, previously de-
scribed within the framework of steady-state enzyme kinet-
ics (Morrison and Walsh, 1988), is straightforward if one
assumes that enzyme-catalyzed reactions may only occur in
block X and subblock X1, respectively. However, because
the concentration of all of the Ai effectors must also be
constant with time as postulated under Materials and Meth-
ods, this hypothesis requires that the products be formed
from Ni
X species (none of the Ai may be reaction products)
and that the rate of product formation be faster than k*on and
k*off (the steady-state and initial rate assumptions should
apply over the time period during which the binding assay
is run, see Note 1). Alternatively, the X block and X1
subblock may also represent transport cycles that either
work under steady-state conditions during the binding assay
or have reached equilibrium at its start, so that all the
reactions at the right of the inhibitor binding step would
occur out of such transport cycles (see examples given in
the Appendix). Accordingly, mechanisms A and B in Fig. 2
may also apply to slow-binding situations on the steady-
state time scale as formally demonstrated below.
Let us assume in Fig. 2 A and B, that a product P can be
generated from any number of Ni
X species with rate constant
(kcat)i, so that the rate of product formation can be expressed as
dP
dt
 
i
kcatiNi
X X 
i
kcati f i
X , (53)
where f i
X Ni
X/X represents the fractional concentrations of
the product-generating Ni
X species. Substituting the time-
dependent expression shown in Eq. 18 for X in Eq. 53 and
integrating over time leads to
P 
i
kcati f i
XXet X0 Xekobs 1 ekobst, (54)
in which X0  NT for both mechanisms A and B (Eq. 23),
Xe is given by Eq. 19 in which Ye is equivalent to Be with
algebraic expressions shown in Tables 1 and 2, and kobs can
be found from Eq. 13 and Table 1. Because the quantities
v0 
i
kcati f i
X X0 (55)
and
ve 
i
kcati f i
X Xe (56)
clearly represent, respectively, the initial velocity and the
final steady-state velocity of product formation in the pres-
ence of inhibitor, Eq. 54 is fully equivalent to
P vst
v0 vs
kobs
1 ekobst, (57)
which is the most general equation used to analyze burst
kinetics of product formation in the steady-state approach
(Morrison and Walsh, 1988). Accordingly, the linear and
Michaelis–Menten forms of the kobs versus [I] plots dem-
onstrated herein for mechanisms A and B, respectively,
fully agree with the similar dependencies on [I] previously
reported for this parameter using elementary counterparts of
these kinetic schemes (Morrison and Walsh, 1988). Note,
then, that our studies extend these previous conclusions to
almost any kinetic scheme and to inhibitors other than
competitive, provided that Eqs. 50 (mechanism B) or 52
(mechanismA) can be applied to a specific kinetic mechanism.
Relevance of mechanism C to
slow-binding inhibitors
To our knowledge, mechanism C depicted in Fig. 2 has
never been analyzed in the context of enzyme kinetics and
may not apply to catalytic systems that demonstrate linear
reaction rates. Indeed, the presence of a slow isomerization
step is reminiscent of a property usually associated with
hysteretic enzymes, which can demonstrate more complex
behavior (Neet and Ainslie, 1980). In contrast, the analogy
between mechanism C and the recruitment hypothesis
(Aronson, 1978) is quite obvious because the extent of
inhibitor binding in block Y2 is conditioned by the rate-
Falk et al. Inhibitor-Binding Mechanisms 183
limiting recruitment of the Ni
X species into block Y. How-
ever, if mechanism C is meant to represent a transport
process, the slow isomerization step should be part of the
transport cycle itself, which raises the question of its rele-
vance to slow-binding inhibition.
As noted earlier (see Materials and Methods and Results
sections), there is a marked difference among the models
A–C depicted in Fig. 2 in that at least part of the inhibitor
molecules bound to the protein in models A and B would be
protected by the rate-limiting step from free exchange with
either the inhibitor itself or the natural substrate, should
these be added to the incubation medium. Accordingly,
debinding of the inhibitor should always be fast in mecha-
nism C under these conditions. For the very same reason,
inhibitor binding may not even be measurable using a
radiotracer technique in combination with a rapid filtration
assay because fast debinding during the washing steps
would be expected with this type of mechanism. Quite
obviously, then, these considerations cast doubt on the
hypothesis that slow phlorizin binding to the Na-D-glucose
cotransporter(s) is due to rate limiting by the free-carrier
recycling step (Aronson, 1978; Toggenburger et al., 1978,
1982; Turner and Silverman, 1981; Restrepo and Kimmich,
1986). In fact, the validity of the recruitment hypothesis can
be assessed directly. As shown in the Appendix, where
mechanism C is considered in relation to the two most
relevant mechanisms of Na-D-glucose cotransport pro-
posed to date (Parent et al., 1992b; Kimmich, 1990; Chen et
al., 1997), the k*on value for binding of a competitive inhib-
itor should, at best, be equal to that estimated for the
turnover number of the catalytic process (kcat) using the
natural substrate under symmetrical conditions. Because Eq.
13 also applies, this is to state that the t1/2 for binding should
always be less than the t1/2 required to perform one catalytic
cycle in this type of mechanisms. Accordingly, with a
turnover number of 5–125 catalytic cycles of Na-glucose
cotransport per second (Kimmich, 1990), it can be con-
cluded that equilibrium binding of phlorizin should be
reached in the subsecond time range and that the recruit-
ment hypothesis does not apply to SGLT1.
Relevance of mechanisms A and B to the
fast-acting slow-binding paradigm
As discussed in the Introduction, the fast-acting slow-bind-
ing paradigm results from the apparent contradiction be-
tween observations originating from the parallel application
of the general and direct approaches to the analysis of
protein-inhibitor interactions in a given system. The fast-
acting behavior seen with the general approach does call
into question the assumption that the steady-state approach
is valid for resolving the slow kinetics of inhibitor binding
observed with the direct approach, but also rules out mech-
anism A as a possible explanation of the slow-binding
kinetics (see Note 3).
Because neither mechanism A nor mechanism C may
explain the fast-acting slow-binding paradigm of phlorizin,
then mechanism B should represent the only alternative
solution. Indeed, the restrictive 0–9-s time range over which
the steady-state kinetics of glucose transport can be assessed
in the absence of inhibitor (Chenu and Berteloot, 1993;
Oulianova and Berteloot, 1996) may preclude the observa-
tion of burst kinetics in its presence because full equilibra-
tion of phlorizin binding requires several minutes (Gloss-
mann and Neville, 1972; Chesney et al., 1974; Aronson,
1978; Turner and Silverman, 1981; Koepsell et al., 1990).
Accordingly, the steady-state inhibition of transport activity
may just be apparent and would mostly reflect the rapid
formation of the initial collision complex. Moreover, be-
cause the inhibitor binding assay in these studies involves a
rapid filtration technique coupled with the use of radioactive
phlorizin, the fast dissociation rates associated with the
initial collision complex could lead to a fast wash out of the
inhibitor molecules bound to this complex during the wash-
ing steps in this experimental design. Accordingly, the slow
kinetics of inhibitor binding would essentially characterize
the slow isomerization of the initial collision complex into
a more stable form, in conformity with the predictions of
mechanism B (occluded) (Tables 1 and 2).
In addition to these theoretical and experimental consid-
erations, there are a number of related results with regard to
phlorizin binding that still remain to be satisfactorily ex-
plained: 1) the Ki value for glucose transport inhibition in
rabbit kidney vesicles, 15 	M as determined by Ou-
lianova and Berteloot (1996) or recalculated by these au-
thors from the data of Turner and Moran (1982a), appears
close to one order of magnitude higher than the Kd value of
phlorizin binding measured at equilibrium (1.7–1.9 	M) in
similar preparations (Turner and Moran, 1982b); 2) in rabbit
intestinal vesicles, the apparent Ki value for glucose trans-
port inhibition decreased from 40–50 	M when measured
at 0.1 s to approx. 7 	M when estimated over the time
interval 1.3–1.8 s (Toggenburger et al., 1982); and 3) in
Xenopus laevis oocytes overexpressing the rabbit SGLT1
clone, the Ki value of30 	M for phlorizin blockade of the
presteady-state current (Hazama et al., 1997) appears sig-
nificantly higher than the Ki value of 2–10 	M for phlorizin
inhibition of the sugar-induced steady-state current (Wright,
1993). Interestingly, all of these observations seem to agree
that the apparent affinity for phlorizin binding may increase
with time, a behavior that can be interpreted as strong
evidence in support of mechanism B (Eq. 48). Still, a final
conclusion to this matter may have to await direct demon-
stration that the kinetics of phlorizin binding do follow
those expected for mechanism B.
APPENDIX: RELATIONSHIP BETWEEN THE
APPARENT FIRST-ORDER RATE OF INHIBITOR
BINDING (kobs) AND THE TURNOVER NUMBER
FOR SUBSTRATE TRANSPORT (kcat) IN THE
RECRUITMENT HYPOTHESIS (MECHANISM C)
The kinetics of phlorizin binding to the SGLT proteins of
renal and intestinal membranes have previously been inter-
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preted according to the recruitment concept (Mechanism C
in Fig. 2), whereby the rate-limiting step in the binding
process is designated by the free-carrier recycling step while
the different carrier species are in equilibrium with the
ligands at the two membrane faces (Aronson, 1978; Turner
and Silverman, 1980). The purpose of this appendix is to
demonstrate that the validity of the recruitment hypothesis
is dependent on the turnover number for transport measured
under symmetrical conditions using the natural substrate.
No consensus has yet been reached as to the order of Na
and substrate (inhibitor) addition on the SGLT1 protein, and
Fig. A1 depicts the two most relevant mechanisms proposed
to date. The N:N:S model (Fig. A1 A) was originally pro-
posed by Parent et al. (1992b) and assumes that the binding
of the two Na ions to the transport protein can be described
as a single reaction step that precedes substrate (inhibitor)
addition, a hypothesis that has since been shown to be
compatible with strong cooperativity for Na binding (Falk
et al., 1998). The N:S:N model (Fig. A1 B), in which the
substrate (inhibitor) binding step occurs between the two
Na binding events, has been advocated by Kimmich’s lab
(Kimmich, 1990) and has received support in a recent paper
by Chen et al. (1997). Note that these two mechanisms are
presented in Fig. A1 to satisfy the rapid equilibrium as-
sumption inherent to the recruitment hypothesis, and that
they have in common a Na leak pathway (N3 to N4
transition) for which evidence has been provided by Parent
et al. (1992a) and by Chen et al. (1997) for the N:N:S and
N:S:N models, respectively. We do not intend to discuss
here the pros and the cons for the two schemes but, rather,
to demonstrate that the same conclusion may apply to both.
The rapid equilibrium assumption allows us to define the
two blocks of elementary reactions called X and Y in Fig.
A1 to emphasize the similarities with model C in Fig. 2. As
discussed in the text, it is possible to reduce both mecha-
nisms to the same elementary scheme shown in Fig. 1 B
using Cha’s formalism (Cha, 1968), and thus to use Eqs. 50
and 51 to write down the equalities
k*on k12 f1 k43 f4 , (A1)
k*off k21 f2 k34 f3 . (A2)
Note that the numbering of the carrier species was chosen in
such a way that Eqs. A1 and A2 may apply to both of the
situations depicted in Fig. A1. The fi fractions can be
calculated as proposed in the text or with the help of a
computer program (Falk et al., 1998); the relevant algebraic
expressions are given in Table A1, as well as those of k*on
and k*off that result from proper substitutions into Eqs. A1
and A2, and from a few arithmetic rearrangements thereaf-
ter. As predicted for mechanism C in Fig. 2 and its associ-
ated kinetic features reported in Table 1, only k*off is affected
by the inhibitor concentration and the value of this param-
eter decreases to zero at saturation. Because Eq. 13 also
applies, the k*on value represents the smallest possible value
for kobs (i.e., the slowest rate of binding that may be
FIGURE A1 Kinetic mechanisms of Na-D-glucose cotransport. (A) The
N:N:S model proposed by Parent et al. (1992b), in which the binding of the
two Na ions to the transport protein is depicted as a single reaction step
that precedes phlorizin (I) or glucose (S) addition. (B) The N:S:N model
proposed by Chen et al. (1997) in which the I or S binding step comes
between the two Na binding events. In both A and B, the full line
represents the elementary reactions and the blocks that need to be consid-
ered to describe phlorizin binding. The extra reactions and block extensions
in dashed lines should also be included to account for glucose transport. The
indices i and o associated with the effectors refer, respectively, to the internal
(IN) and external (OUT) location of these effectors relative to their binding
sites on the transport protein. The naming of the X and Y blocks was chosen
to emphasize the similarity of these models with mechanism C in Fig. 2.
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achieved). The comparison between k*on and the turnover
rate of substrate transport (kcat) may thus prove necessary
and sufficient to predict the time scale over which the
kinetics of inhibitor binding may be observed in a realistic
experiment.
Both phlorizin binding and glucose transport studies have
usually been performed with membrane vesicles (Aronson,
1978; Chesney et al., 1974; Glossmann and Neville, 1972;
Koepsell et al., 1990; Toggenburger et al., 1978, 1982;
Turner and Moran, 1982b; Turner and Silverman, 1981) or
epithelial cells (Moran et al., 1988; Restrepo and Kimmich,
1986) in the complete absence of internal substrate while
the Na concentration was varied in both the external and
internal media. To perform the comparison detailed above,
one may only need to establish the algebraic expression of
kcat under initial rate conditions of transport when Si  0.
This is most easily done by first deriving the velocity
equations relative to substrate transport (vi
s) using a computer
program (Falk et al., 1998) with resultant Eqs. A3 and A4,
vi
S
NT

C1 C2Nai2	Nao2So
C3 C4Nai2 C5 C6Nai2	Nao2
 C7 C8Nai2	Nao2So
, (A3)
vi
S
NT

C1 C2Nai	Nao2So
C3 C4Nai C5 C6Nai	Nao
C7 C8Nai C9 C10Nai	NaoNaoSo
,
(A4)
for the N:N:S and N:S:N models, respectively, in which the
algebraic expressions of the macro constants (Ci) are given
in Table A2. Because
kcat
Vmax
NT
, (A5)
where Vmax represents the apparent maximum rate of trans-
port, kcat can be obtained from Eqs. A3 and A4 by dividing
the (So) coefficient term in the numerator by the (So) coef-
ficient term in the denominator, which results in the alge-
braic expressions of kcat shown in Table A2 following
proper substitutions and calculations. With the factorization
used to report the algebraic expressions of k*on and kcat in
Tables A1 and A2, it is readily apparent that the k*on/kcat
ratio can be cast in the forms
k*on
kcat
 1
k12K14 k43Nai2
k56K14 Nai2	
 1, (A6)
TABLE A1 Algebraic expressions of the fi fractions characterizing the Ni species involved in the relaxation process, and of the
apparent first-order rates for inhibitor association to (k*on) and dissociation from (k*off) the transporter
Parameters
Kinetic Mechanisms
N:N:S model
(Fig. A1 A)
N:S:N model
(Fig. A1 B)
f1 K14/D
X K14/D
X
f2 K23K35/D
Y K23K35K56/D
Y
f3 K35(Nao)
2/DY K35K56(Nao)/D
Y
f4 (Nai)
2/DX (Nai)/D
X
k*on [k12K14k43(Nai)
2]/DX [k12K14k43(Nai)]/D
X
k*off {K35[k21K23k34(Nao)
2]}/DY {K35K56[k21K23k34(Nao)]}/D
Y
DX K14(Nai)
2 K14(Nai)
DY K35[K23(Nao)
2](Nao)
2(Io) K35K56[K23(Nao)][K56(Nao)](Nao)(Io)
The fi fractions are defined as the Ni/X or Ni/Y ratios where X and Y represent i Ni in blocks X and Y in Fig. A1 with algebraic expressions as given by
the temporary constants DX and DY. All the other constants and symbols are explicitly defined in Fig. A1.
TABLE A2 Algebraic expressions of the macro constants (Ci) appearing in the initial velocity Eqs. A3 and A4, and of the
turnover number (kcat) for substrate transport
Constants
Kinetic Mechanisms
N:N:S model
(Fig. A1 A)
N:S:N model
(Fig. A1 B)
C1 k12k56K14 k12k67K14
C2 k43k56 k43k67
C3 (k12  k21)K14K23K35 (k12  k21)K14K23K35K56
C4 (k21  k43)K23K35 (k21  k43)K23K35K56
C5 (k12  k34)K14K35 (k12  k34)K14K35K56
C6 (k34  k43)K35 (k34  k43)K35K56
C7 (k12  k56)K14 k12K14K56
C8 k43  k56 k43K56
C9 — (k12  k67)K14
C10 — k43  k67
kcat
k56k12K14 k43Nai2	
k56K14 Nai2	 k12K14 k43Nai2
k67k12K14 k43Nai	Nao
k67NaoK14 Nai	 K56 Nao	k12K14 k43Nai	
The algebraic expressions of kcat were calculated as described in the text. All the other constants and symbols are explicitly defined in Fig. A1.
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k*on
kcat
 1
K56 Nao	k12K14 k43Nai	
k67NaoK14 Nai	
 1, (A7)
for the N:N:S and N:S:N models, respectively. Accordingly,
the time course of phlorizin binding should proceed over a
time scale that is at best equivalent to that required to
perform one catalytic cycle of glucose transport or, to state
otherwise, equilibrium binding of the inhibitor should have
been reached at a time when steady-state kinetics of glucose
transport are observed. In the particular case of SGLT1, for
which a turnover number of 5–125 catalytic cycles per
second has been reported under a large spectrum of exper-
imental conditions (Kimmich, 1990), equilibrium binding of
phlorizin should thus be attained in the subsecond time
range, hence the conclusion in the main text that the recruit-
ment hypothesis does not apply to SGLT1. For both the
N:N:S and N:S:N models, note that this conclusion is inde-
pendent of whether or not there is a Na leak pathway
(k43  0 in Eqs. A6 and A7) and that, in the absence of such
a pathway, saturating concentrations of internal Na leads
to k*on  kcat.
NOTES
1. The substrate concentration can be regarded as constant while the
product concentration remains sufficiently low, so that the steady-state
distribution of the different enzyme species is not affected by substrate
depletion or product formation and the reverse reaction is insignificant.
2. If the rates of inhibitor association with and dissociation from the
protein are fast in mechanism A, or if the forward and reverse isomeriza-
tion rates associated with mechanism B are relatively high, the change in
going from the initial to the final steady-state rate could be rapid and
essentially undetectable by these procedures.
3. Should mechanism A apply to such situations, the tested compound
may fail to reveal itself as an inhibitor of the reaction under study (there is
not enough EI complex formed during velocity measurements to signifi-
cantly inhibit the enzyme reaction). Similarly, in mechanism B, a molecule
with the properties of a slow-binding inhibitor may appear to behave as a
classical inhibitor (only the rapidly formed initial collision complex would
significantly contribute to enzyme inhibition during velocity measurements).
4. Indeed, binding of a fast-acting inhibitor should be complete by the
time steady-state rates of catalytic reactions are measured. By contrast, the
time constant accounting for the binding of slow-binding inhibitors should
be identical to that describing the burst kinetics of the catalytic reaction
under symmetrical conditions.
5. Note that the observation of monoexponential kinetics under prest-
eady-state conditions may not easily be achieved in the presence of many
effectors, some of which may bind to and dissociate from the protein at
very similar rates. However, the experimental conditions may be worked
out to isolate part of a reaction sequence that may be reduced to the basic
schemes shown in Fig. 2, in which I may now stand for any type of effector
involved in the reaction sequence.
6. To compare the present analyses and the previous studies of Wierz-
bicki et al. (1990), note that Table 4 in the latter article reports the algebraic
expressions of 1/ and that the parameter  is equivalent to kobs in the
former.
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